agilon health Investors Face March 2, 2026 Deadline to Seek Lead Plaintiff Status in Securities Class Action Lawsuit

Updated onJan 3, 2026
agilon health Investors Face March 2, 2026 Deadline to Seek Lead Plaintiff Status in Securities Class Action Lawsuit

Summary

Rosen Law Firm, a global investor rights law firm, has filed a securities class action lawsuit against agilon health, inc. (AGL) on behalf of investors who purchased securities between February 26, 2025, and August 4, 2025. The lawsuit alleges violations of federal securities laws. Investors seeking to serve as lead plaintiff in the action must file a motion with the Court no later than the critical deadline of March 2, 2026, as the litigation proceeds.

Rosen Law Firm filed a securities class action against agilon health, inc. The lawsuit covers investors who purchased AGL securities during the Class Period. The critical deadline for lead plaintiff status is set for March 2, 2026.

Key Takeaways

  • The Class Period for the AGL securities lawsuit runs from February 26, 2025, to August 4, 2025.
  • Investors must move the Court by March 2, 2026, to seek lead plaintiff appointment.
  • The litigation introduces financial and reputational risks for agilon health, inc.

Sentiment: Bearish

The initiation of a class action lawsuit typically signals negative legal risk for the company.

Disclaimer: This is an AI-generated summary of a press release . The model used to summarize this release may make mistakes. See the full release here.

Receive $AGL Data Alerts

Sign Up

Latest News